| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/18/2001 | EP1115296A1 Nutritional and pharmaceutical compositions |
| 07/18/2001 | EP1115295A2 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
| 07/18/2001 | EP0949905B1 Injectable depot gel composition and method of preparing the composition |
| 07/18/2001 | EP0848611B1 Tacrine patch |
| 07/18/2001 | EP0814772B1 Pectin pharmaceutical compositions |
| 07/18/2001 | EP0758235B1 Polymer coated tablet comprising amoxycillin and clavulanate |
| 07/18/2001 | EP0616508B1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/18/2001 | CN1304450A Novel insulin analogs with enhanced zinc binding |
| 07/18/2001 | CN1304423A Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polythylene glycol, and polyorthoester-polyethylene-glycol-polyorthoester block cpolymers |
| 07/18/2001 | CN1304416A Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and use |
| 07/18/2001 | CN1304322A Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 07/18/2001 | CN1304321A Composition for transdermal administration of non-steroidal anti-inflammatory drugs |
| 07/18/2001 | CN1304314A Extracts of i(hypericum perforatum) and formulations containing them |
| 07/18/2001 | CN1304308A Aqueous process for manufacturing paroxetine solid dispersions |
| 07/18/2001 | CN1304290A Pulmonary and nasal delivery of Raloxifene |
| 07/18/2001 | CN1303711A Aloe glossy ganoderma ultra-fine powder |
| 07/18/2001 | CN1303705A Smoking medicine for curing rhinitis |
| 07/18/2001 | CN1303703A External powder for curing rheumatism involving bone and its preparation method |
| 07/18/2001 | CN1303697A Pain-stopping medicine for external application for curing cancers |
| 07/18/2001 | CN1303696A Aloe ant ultra-fine powder |
| 07/18/2001 | CN1303691A Health-care Chinese herbal medicine cigarette for stopping smoking and its formula |
| 07/18/2001 | CN1303684A Dieda fengshi zhitonggao adhesive plaster for curing traumatic injury and rheumatism and its production method |
| 07/18/2001 | CN1303678A Production process of bio-active forest frog's oviduct soft capsule |
| 07/18/2001 | CN1303674A Alprazolam nasal spray |
| 07/18/2001 | CN1303670A Product with powder stable vitamine and/or carotenoid and its producing process |
| 07/18/2001 | CN1068518C Wettable powder of niclosamide salt |
| 07/18/2001 | CN1068516C Dual alcohol injection |
| 07/17/2001 | US6262255 Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262126 Semi-fluorinated alkanes and their use |
| 07/17/2001 | US6262121 Oily patches for external use containing diclofenac sodium |
| 07/17/2001 | US6262117 Method and composition for treating acne |
| 07/17/2001 | US6262115 Admitting orally into the patient a dosage form of oxybutynin and its pharmaceutically acceptable salt, that is administered once-a-day as sustained-release form for management of incontinence |
| 07/17/2001 | US6262086 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole; antisecretory agents |
| 07/17/2001 | US6262085 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/17/2001 | US6262079 Prevention and treatment of cardiovascular pathologies |
| 07/17/2001 | US6262072 Orally administered antimicrobial pharmaceutical formulations of ciprofloxacin |
| 07/17/2001 | US6262050 Topical composition containing capsazepine |
| 07/17/2001 | US6262041 Topically administering the compound 26, 27-hexafluoro-1,25-dihydroxy vitamin d3 to the skin |
| 07/17/2001 | US6262034 Polymeric gene delivery system |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6262022 Carrier medium comprises: 1,2-propylene glycol; mixture of c.sub.12-20 fatty acid mono-, di-, and tri-glycerides; surfactant. |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6262020 Topical wound therapeutic compositions |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261835 Nucleotide sequences encoding osteogenic proteins |
| 07/17/2001 | US6261752 Alkaline soluble mixture composed of cellulose derivatives |
| 07/17/2001 | US6261602 Pharmaceutical composition for rapid suspension in aqueous media |
| 07/17/2001 | US6261601 Orally administered controlled drug delivery system providing temporal and spatial control |
| 07/17/2001 | US6261600 Mixture containing neutralized alkaline compound |
| 07/17/2001 | US6261599 Sustained release |
| 07/17/2001 | US6261598 Carotenoid formulations, comprising a mixture of B-carotens, lycopene and lutein |
| 07/17/2001 | US6261597 Method for treating periodontal disease |
| 07/17/2001 | US6261596 Method to provide for production of hair coloring pigments in hair follicles |
| 07/17/2001 | US6261595 Containing heat exchanger |
| 07/17/2001 | US6261593 Supplying petroleum jelly |
| 07/17/2001 | US6261589 Dietary supplement nutrient soft drink composition with psychoactive effect |
| 07/17/2001 | US6261588 Administering mushroom extract |
| 07/17/2001 | US6261587 Contacting with matrix containing gelatin and nitric acid inhibitor |
| 07/17/2001 | US6261585 Increasing blood flow to ischemic aanimal tissue |
| 07/17/2001 | US6261583 Moldable solid delivery system |
| 07/17/2001 | US6261582 Analgesic paste containing collagen |
| 07/17/2001 | US6261577 Topical applying mixture of iodine and halide |
| 07/17/2001 | US6261547 Solutions for vision defects, anesthetics |
| 07/17/2001 | US6261546 Methods and compositions for stabilizing acetylcholine compositions |
| 07/17/2001 | US6261545 Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | US6261539 Medicine, propellants, stabilizers and dispersants |
| 07/17/2001 | US6261405 Method and apparatus for making a patch |
| 07/17/2001 | CA2261500C Stable oxaliplatin solutions and their use in cytostatic antineoplastic treatment |
| 07/17/2001 | CA2197320C Stable water-in-oil emulsion system |
| 07/17/2001 | CA2173543C Ceramide-type compounds, process for their preparation and uses thereof |
| 07/17/2001 | CA2034025C Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
| 07/17/2001 | CA2016039C Extended release pharmaceutical formulations |
| 07/12/2001 | WO2001049869A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | WO2001049822A2 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 07/12/2001 | WO2001049696A1 N,o-amidomalonate platinum complexes |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049407A1 Method for collecting and encapsulating fine particles |
| 07/12/2001 | WO2001049350A1 Aerosol inhaler |
| 07/12/2001 | WO2001049324A2 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | WO2001049314A2 Glp-2 formulations |
| 07/12/2001 | WO2001049311A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | WO2001049307A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | WO2001049304A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049296A1 Antimicrobial compositions and methods of use |
| 07/12/2001 | WO2001049292A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | WO2001049286A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 07/12/2001 | WO2001049285A1 Flavonoid drug and dosage form, its production and use |
| 07/12/2001 | WO2001049280A2 Weight promoting composition, method, and product |
| 07/12/2001 | WO2001049277A2 Immune response modulation |
| 07/12/2001 | WO2001049276A2 Anhydrous gel comprising nsaid for topical administration to the oral cavity |
| 07/12/2001 | WO2001049274A2 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | WO2001049273A2 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation |
| 07/12/2001 | WO2001049272A2 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| 07/12/2001 | WO2001049271A1 Use of a water-soluble agent containing polyglycerols for lubricating extrusions, in particular strips |